Listing on the Nasdaq Global Market. The common stock of the Company is listed on the Nasdaq Global Market under the ticker symbol “ALTH”. The Company has not received any notice that it is not in compliance with the listing requirements of the Nasdaq Global Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be (except as a result of minimum trading price requirements), in compliance with all such listing requirements. There are no affiliations with the Financial Industry Regulatory Authority (the “FINRA”) among the Company’s officers or directors. A registration statement relating to the Common Stock on Form 8-A or other applicable form under the Exchange Act has become effective.
Appears in 2 contracts
Samples: Purchase Agreement (Allos Therapeutics Inc), Purchase Agreement (Allos Therapeutics Inc)
Listing on the Nasdaq Global Market. The common stock Common Stock of the Company is listed on the Nasdaq Global Market under the ticker symbol “ALTHMNKD”. The Company has not received any notice that it is not in compliance with the listing requirements of the Nasdaq Global Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be (except as a result of minimum trading price requirements), in compliance with all such listing requirements. There are no affiliations with the Financial Industry Regulatory Authority (the “FINRA”) NASD among the Company’s officers or directors. A registration statement relating to the Common Stock on Form 8-A or other applicable form under the Exchange Act has become effective.
Appears in 2 contracts
Samples: Mannkind Corp, Mannkind Corp
Listing on the Nasdaq Global Market. The common stock of the Company is listed on the Nasdaq Global Market under the ticker symbol “"ALTH”". The Company has not received any notice that it is not in compliance with the listing requirements of the Nasdaq Global Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be (except as a result of minimum trading price requirements), in compliance with all such listing requirements. There are no affiliations with the Financial Industry Regulatory Authority (the “"FINRA”") among the Company’s 's officers or directors. A registration statement relating to the Common Stock on Form 8-A or other applicable form under the Exchange Act has become effective.
Appears in 1 contract
Listing on the Nasdaq Global Market. The common stock of the Company is listed on the Nasdaq Global Market under the ticker symbol “ALTHZGEN”. The Company has not received any notice that it is not in compliance with the listing requirements of the Nasdaq Global Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be (except as a result of minimum trading price requirements), in compliance with all such listing requirements. There are no affiliations with the Financial Industry Regulatory Authority (the “FINRA”) among the Company’s officers or directors. A registration statement relating to the Common Stock on Form 8-A or other applicable form under the Exchange Act has become effective.
Appears in 1 contract